Neuromuscular diseases don’t stop progressing when a patient walks out of the clinic. So why should our measurements?
Continuous, real-world monitoring captures the daily reality of living with a neuromuscular condition. At this year’s World Muscle Society Congress, we’re showcasing how our wearable, Syde®, puts this into practice.
Real-World Data Across ALS, DMD, and DM1
This year, four posters present the latest data generated with Syde® across several neuromuscular diseases.
Amyotrophic Lateral Sclerosis (ALS)
- Poster #1.57eP
Continuous Real-World Assessment of Ambulation in Amyotrophic Lateral Sclerosis Using Digital Health Technology
Presented by Camila González Barral, Sysnav Healthcare, in collaboration with Harvard University
Duchenne Muscular Dystrophy (DMD)
- Poster #2.34P: Predicting the 95th Centile Stride Velocity (SV95C) at 6-, 12-, 18-, and 24-Months in Steroid-Treated Boys with Duchenne Muscular Dystrophy
Presented by Georgia Stimpson, University of Oxford - Poster #2.36P: Walk like an Egyptian”: Comparing the Natural History of Egyptian and European Duchenne Muscular Dystrophy Patients in a Prospective Multicentre Study
Presented by Sherry Kodsy, Galaa Military Medical Complex, Cairo, in collaboration with Laurent Servais, University of Oxford
Myotonic Dystrophy Type 1 (DM1):
- Poster #4.61PEvaluation of Ambulatory Function with a Wearable Sensor in Myotonic Dystrophy Type 1
Presented by Damien Eggenspieler, Sysnav Healthcare
Meet the team
Yacine Bechichi, Head of Partnerships, and Damien Eggenspieler, Healthcare Program Director, will be on site and would love to meet you.
